Recent Updates
Recently added Catalysts
AEON

Priveterra Acquisition Corp. Announces the Separate Trading of its Common Stock and Warrants, Commencing

Key Takeaway: Acquisition Corp. Announces the Separate Trading of its Common Stock and Warrants, Commencing April 1, 2021 Lauderdale - March 25, 2020 - Priveterra Acquisition Corp. (Nasdaq: PMGMU) (the "Company") today announced that, commencing April 1, 2021, holders of the units sold in t

Full Press Release Details

Acquisition Corp. Announces the Separate Trading of its
Common Stock and Warrants, Commencing April 1, 2021
Lauderdale - March 25, 2020 - Priveterra Acquisition Corp. (Nasdaq: PMGMU) (the "Company") today announced
that, commencing April 1, 2021, holders of the units sold in the Company's initial public offering may elect to separately trade
shares of the Company's Class A common stock and warrants included in the units.
fractional warrants will be issued upon separation of the units and only whole warrants will trade. The shares of Class A common stock
and warrants that are separated will trade on the Nasdaq Capital Market under the symbols "PMGM" and "PMGMW,"
respectively. Those units not separated will continue to trade on the Nasdaq Capital Market under the symbol "PMGMU." Holders
of units will need to have their brokers contact Continental Stock Transfer & Trust Company, the Company's transfer agent,
in order to separate the units into shares of Class A common stock and warrants.
Acquisition Corp. is a blank-check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase,
reorganization or similar business combination with one or more businesses. The Company intends to seek a target in medical technology.
Fargo Securities and Guggenheim Securities acted as the joint book-runners for the offering. Odeon Capital Group acted as co-manager
offering was made only by means of a prospectus. Copies of the prospectus relating to this offering may be obtained from Wells Fargo
Securities, LLC, Attention: Equity Syndicate Department, 500 West 33rd Street, New York, New York, 10001, at (800) 326-5897 or emailing
a request to cmclientsupport@wellsfargo.com and Guggenheim Securities, LLC, Attention: Equity Syndicate Department, 330 Madison Avenue,
New York, NY 10017 or by telephone at (212) 518-5548, or by email at GSEquityProspectusDelivery@guggenheimpartners.com.
registration statement relating to these securities was declared effective by the SEC on February 8, 2021. This press release shall not
constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction
in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such
state or jurisdiction.
press release contains statements that constitute "forward-looking statements," including with respect to the search for
an initial business combination. No assurance can be given that the proceeds of the offering will be used as indicated.
Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those
set forth in the Risk Factors section of the Company's registration statement and prospectus for the initial public
offering filed with the SEC. Copies are available on the SEC's website, www.sec.gov. The Company undertakes no obligation to
update these statements for revisions or changes after the date of this release, except as required by law.
Legal Officer and Secretary
Last updated: Mar 26, 2021